Emergence of Cowpox: Study of the Virulence of Clinical Strains and Evaluation of Antivirals

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Duraffour, Sophie ^a   Mertens, Barbara ^a   Meyer, Hermann ^b   van den Oord, Joost J ^c   Mitera, Tania ^a   Matthys, Patrick ^a   Snoeck, Robert ^a   Andrei, Graciela ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b BUNDESWEHR INSTITUTE OF MICROBIOLOGY   (Germany)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR; CIDOFOVIR 3 HEXADECYLOXYPROPYL ESTER; INTERLEUKIN 6; TECOVIRIMAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; COWPOX; COWPOX VIRUS; DISEASE SEVERITY; EMBRYO; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MORTALITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; STRAIN DIFFERENCE; VIROGENESIS; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; COWPOX; COWPOX VIRUS; FEMALE; HUMANS; INTERLEUKIN-6; LUNG; MICE; PHYLOGENY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84874073752     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055808     Document Type: Article

References (36)

1. Campe H, Zimmermann P, Glos K, Bayer M, Bergemann H, et al. (2009) Cowpox virus transmission from pet rats to humans, Germany. Emerg Infect Dis 15: 777-780.
2. Kurth A, Straube M, Kuczka A, Dunsche AJ, Meyer H, et al. (2009) Cowpox virus outbreak in banded mongooses (Mungos mungo) and jaguarundis (Herpailurus yagouaroundi) with a time-delayed infection to humans. PLoS One 4: e6883.
3. Ninove L, Domart Y, Vervel C, Voinot C, Salez N, et al. (2009) Cowpox virus transmission from pet rats to humans, France. Emerg Infect Dis 15: 781-784.
4. Vogel S, Sardy M, Glos K, Korting HC, Ruzicka T, et al. (2012) The Munich outbreak of cutaneous cowpox infection: transmission by infected pet rats. Acta Derm Venereol 92: 126-131.
5. Baxby D, Bennett M, Getty B, (1994) Human cowpox 1969-93: a review based on 54 cases. Br J Dermatol 131: 598-607.
6. Haase O, Moser A, Rose C, Kurth A, Zillikens D, et al. (2011) Generalized cowpox infection in a patient with Darier disease. Br J Dermatol 164: 1116-1118.
7. Eis-Hubinger AM, Gerritzen A, Schneweis KE, Pfeiff B, Pullmann H, et al. (1990) Fatal cowpox-like virus infection transmitted by cat. Lancet 336: 880.
8. Pelkonen PM, Tarvainen K, Hynninen A, Kallio ER, Henttonen K, et al. (2003) Cowpox with severe generalized eruption, Finland. Emerg Infect Dis 9: 1458-1461.
9. Bennett M, Crouch AJ, Begon M, Duffy B, Feore S, et al. (1997) Cowpox in British voles and mice. Journal of Comparative Pathology 116: 35-44.
10. Kinnunen PM, Henttonen H, Hoffmann B, Kallio ER, Korthase C, et al. (2011) Orthopox virus infections in Eurasian wild rodents. Vector Borne Zoonotic Dis 11: 1133-1140.
11. Becker C, Kurth A, Hessler F, Kramp H, Gokel M, et al. (2009) Cowpox virus infection in pet rat owners: not always immediately recognized. Dtsch Arztebl Int 106: 329-334.
12. Hostetler KY, (2010) Synthesis and early development of hexadecyloxypropylcidofovir: an oral antipoxvirus nucleoside phosphonate. Viruses 2: 2213-2225.
13. Andrei G, Snoeck R, (2010) Cidofovir Activity against Poxvirus Infections. Viruses 2: 2803-2830.
14. Duraffour S, Andrei G, Snoeck R, (2010) Tecovirimat, a p37 envelope protein inhibitor for the treatment of smallpox infection. IDrugs 13: 181-191.
15. Baxby D, (1975) Laboratory Characteristics of British and Dutch Strains of Cowpox Virus. Zentralblatt fur Veterinarmedizin Reihe B-Journal of Veterinary Medicine Series B-Infectious Diseases Immunology Food Hygiene Veterinary Public Health 22: 480-487.
16. Carroll DS, Emerson GL, Li Y, Sammons S, Olson V, et al. (2011) Chasing Jenner's vaccine: revisiting cowpox virus classification. PLoS One 6: e23086.
17. Duraffour S, Matthys P, van Den Oord JJ, De Schutter T, Mitera T, et al. (2011) Study of camelpox virus pathogenesis in athymic nude mice. PLoS One 6: e21561.
18. Duraffour S, Snoeck R, Krecmerova M, Van den OJ, de Vos R, et al. (2007) Activities of several classes of acyclic nucleoside phosphonates against camelpox virus replication in different cell culture models. Antimicrob Agents Chemother 51: 4410-4419.
19. Duraffour S, Andrei G, Topalis D, Krecmerova M, Crance JM, et al. (2012) Mutations conferring resistance to viral DNA polymerase inhibitors in camelpox virus give different drug-susceptibility profiles in vaccinia virus. J Virol 86: 7310-7325.
20. Alzhanova D, Fruh K, (2010) Modulation of the host immune response by cowpox virus. Microbes Infect 12: 900-909.
21. Naugler WE, Karin M, (2008) The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends Mol Med 14: 109-119.
22. Smee DF, Gowen BB, Wandersee MK, Wong MH, Skirpstunas RT, et al. (2008) Differential pathogenesis of cowpox virus intranasal infections in mice induced by low and high inoculum volumes and effects of cidofovir treatment. Int J Antimicrob Agents 31: 352-359.
23. Bourquain D, Nitsche A (2012) Cowpox virus but not Vaccinia virus induces secretion of CXCL1, IL-8 and IL-6 and chemotaxis of monocytes in vitro. Virus Res, In press.
24. Johnson RF, Yellayi S, Cann JA, Johnson A, Smith AL, et al. (2011) Cowpox virus infection of cynomolgus macaques as a model of hemorrhagic smallpox. Virology 418: 102-112.
25. Smith AL, St CM, Yellayi S, Bollinger L, Jahrling PB, et al. (2012) Intrabronchial inoculation of cynomolgus macaques with cowpox virus. J Gen Virol 93: 159-164.
26. Reading PC, Smith GL, (2003) A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection. J Gen Virol 84: 1973-1983.
27. Fenner F, Burnet FM, (1957) A short description of the poxvirus group (vaccinia and related viruses). Virology 4: 305-314.
28. Parker RF, Bronson LH, Green RH, (1941) Further studies of the infectious unit of vaccinia. J Exp Med 74: 263-281.
29. Huemer HP, Lassnig C, Nowotny N, (2012) Cowpox virus isolate virulent in humans shows attenuated phenotype in mice. Res Vet Sci 92: 333-337.
30. Breithaupt A, Kalthoff D, Deutskens F, Konig P, Hoffmann B, et al. (2012) Clinical Course and Pathology in Rats (Rattus norvegicus) After Experimental Cowpox Virus Infection by Percutaneous and Intranasal Application. Vet Pathol 49: 941-9.
31. Rubins KH, Hensley LE, Relman DA, Brown PO, (2011) Stunned silence: gene expression programs in human cells infected with monkeypox or vaccinia virus. PLoS One 6: e15615.
32. Rubins KH, Hensley LE, Jahrling PB, Whitney AR, Geisbert TW, et al. (2004) The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model. Proc Natl Acad Sci U S A 101: 15190-15195.
33. Feore SM, Bennett M, Chantrey J, Jones T, Baxby D, et al. (1997) The effect of cowpox virus infection on fecundity in bank voles and wood mice. Proc Biol Sci 264: 1457-1461.
34. Gaskell RM, Gaskell CJ, Evans RJ, Dennis PE, Bennett AM, et al. (1983) Natural and experimental pox virus infection in the domestic cat. Vet Rec 112: 164-170.
35. Burthe S, Telfer S, Begon M, Bennett M, Smith A, et al. (2008) Cowpox virus infection in natural field vole Microtus agrestis populations: significant negative impacts on survival. J Anim Ecol 77: 110-119.
36. Duraffour S, Vigne S, Vermeire K, Garcel A, Vanstreels E, et al. (2008) Specific targeting of the F13L protein by ST-246 affects orthopoxvirus production differently. Antiviral Therapy 13: 977-990.